We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Oncurious NV, BioInvent and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma

News   May 03, 2016

 
Oncurious NV, BioInvent and NMTRC Initiating Phase I/IIa Study with TB-403 for the Treatment of Medulloblastoma
 
 
Advertisement
 

RELATED ARTICLES

Monitoring Skin Cancer Using Molecules in Urine

News

Researchers at Pavol Jozef Šafárik University in Košice, Slovakia, have identified fluorescent molecules in urine that correlate with melanoma progression, creating new possibilities for monitoring the disease.

READ MORE

Cell Signaling Insight Helps the Hunt for Effective Anticancer Drugs

News

A team of researchers has revealed key biochemical processes that advance our understanding of colorectal cancer, this knowledge could help in the search for effective anticancer drugs.

READ MORE

Russia’s COVID-19 Vaccine “Approved" Despite No Phase III Data

News

The scientific community has been left somewhat perplexed today after Russian President Vladamir Putin announced that Russian authorities have approved the world's first COVID-19 vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE